Piper Jaffray 19th Annual Healthcare Conference to Webcast Millennium Presentation

Wednesday, November 21, 2007 General News J E 4
CAMBRIDGE, Mass., Nov. 20 MillenniumPharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation atthe Piper Jaffray 19th Annual Healthcare Conference will be webcast live andmay be accessed by visiting the Investors section of the Company's website,

(Logo: )

The presentation will include an overview of the Company, an update onclinical trials for VELCADE(R) (bortezomib) for Injection and other productcandidates, and a review of upcoming milestones. The presentation will bedelivered at 11:30 a.m. ET on Wednesday, November 28, 2007 from the PierreHotel in New York City. The presentation will be archived for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical companybased in Cambridge, Mass., markets VELCADE, a novel cancer product, and has arobust clinical development pipeline of product candidates. The Company'sresearch, development and commercialization activities are focused in twotherapeutic areas: oncology and inflammation. By applying its knowledge ofthe human genome, understanding of disease mechanisms and industrialized drugdiscovery platform, Millennium is developing an exciting pipeline ofinnovative product candidates. The Company's website is

Editors' Note: This press release is also available under the Mediasection of the Company's website at:


Kyle Kuvalanka

(617) 761-4734

SOURCE Millennium Pharmaceuticals, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
CardioMag Announces Results of 2006 Annual Shareho...
BMO Capital Markets Healthcare Conference to Webca...